Ayadi, AE and Zigmond, MJ
(2011)
Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: Mechanistic study.
PLoS ONE, 6 (10).
Abstract
Mild stress can protect against a larger insult, a phenomenon termed preconditioning or tolerance. To determine if a low intensity stressor could also protect cells against intense oxidative stress in a model of dopamine deficiency associated with Parkinson disease, we used methamphetamine to provide a mild, preconditioning stress, 6-hydroxydopamine (6-OHDA) as a source of potentially toxic oxidative stress, and MN9D cells as a model of dopamine neurons. We observed that prior exposure to subtoxic concentrations of methamphetamine protected these cells against 6-OHDA toxicity, whereas higher concentrations of methamphetamine exacerbated it. The protection by methamphetamine was accompanied by decreased uptake of both [ 3H] dopamine and 6-OHDA into the cells, which may have accounted for some of the apparent protection. However, a number of other effects of methamphetamine exposure suggest that the drug also affected basic cellular survival mechanisms. First, although methamphetamine preconditioning decreased basal pERK1/2 and pAkt levels, it enhanced the 6-OHDA-induced increase in these phosphokinases. Second, the apparent increase in pERK1/2 activity was accompanied by increased pMEK1/2 levels and decreased activity of protein phosphatase 2. Third, methamphetamine upregulated the pro-survival protein Bcl-2. Our results suggest that exposure to low concentrations of methamphetamine cause a number of changes in dopamine cells, some of which result in a decrease in their vulnerability to subsequent oxidative stress. These observations may provide insights into the development of new therapies for prevention or treatment of PD. © 2011 El Ayadi, Zigmond.
Share
| Citation/Export: |
|
| Social Networking: |
|
Details
| Item Type: |
Article
|
| Status: |
Published |
| Creators/Authors: |
| Creators | Email | Pitt Username | ORCID  |
|---|
| Ayadi, AE | | | | | Zigmond, MJ | nbd@pitt.edu | NBD | |
|
| Contributors: |
| Contribution | Contributors Name | Email | Pitt Username | ORCID |
|---|
| Editor | Cookson, Mark R. | UNSPECIFIED | UNSPECIFIED | UNSPECIFIED |
|
| Date: |
12 October 2011 |
| Date Type: |
Publication |
| Journal or Publication Title: |
PLoS ONE |
| Volume: |
6 |
| Number: |
10 |
| DOI or Unique Handle: |
10.1371/journal.pone.0024722 |
| Refereed: |
Yes |
| MeSH Headings: |
Animals; Cell Death--drug effects; Cell Line; Cytoprotection--drug effects; Dopamine--metabolism; Dopamine Plasma Membrane Transport Proteins--metabolism; Dopaminergic Neurons--drug effects; Dopaminergic Neurons--enzymology; Dopaminergic Neurons--pathology; Dose-Response Relationship, Drug; Enzyme Activation--drug effects; Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors; Extracellular Signal-Regulated MAP Kinases--metabolism; JNK Mitogen-Activated Protein Kinases--metabolism; Methamphetamine--pharmacology; Methamphetamine--toxicity; Mice; Mice, Inbred C57BL; Neuroprotective Agents--pharmacology; Neuroprotective Agents--toxicity; Oxidative Stress--drug effects; Oxidopamine--toxicity; Phosphorylation--drug effects; Protein Phosphatase 2--metabolism; Proto-Oncogene Proteins c-akt--metabolism; Proto-Oncogene Proteins c-bcl-2--metabolism; Protons; Superoxide Dismutase--metabolism |
| Other ID: |
NLM PMC3192034 |
| PubMed Central ID: |
PMC3192034 |
| PubMed ID: |
22022363 |
| Date Deposited: |
10 Sep 2012 14:12 |
| Last Modified: |
03 Jul 2024 10:55 |
| URI: |
http://d-scholarship.pitt.edu/id/eprint/13982 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
 |
View Item |
![[img]](https://d-scholarship.pitt.edu/style/images/fileicons/text_plain.png)
![[feed]](/images/feed-icon-32x32.png){kind=icon}